N-acetyl-L-cysteine_NN
inhibits_VBZ
primary_JJ
human_JJ
T_NN
cell_NN
responses_NNS
at_IN
the_DT
dendritic_JJ
cell_NN
level_NN
:_:
association_NN
with_IN
NF-kappaB_NN
inhibition_NN
._.

N-acetyl-L-cysteine_NN
-LRB-_-LRB-
NAC_NN
-RRB-_-RRB-
is_VBZ
an_DT
antioxidant_JJ
molecule_NN
endowed_JJ
with_IN
immunomodulatory_JJ
properties_NNS
._.

To_TO
investigate_VB
the_DT
effect_NN
of_IN
NAC_NN
on_IN
the_DT
induction_NN
phase_NN
of_IN
T_NN
cell_NN
responses_NNS
,_,
we_PRP
analyzed_VBD
its_PRP$
action_NN
on_IN
human_JJ
dendritic_JJ
cells_NNS
-LRB-_-LRB-
DC_NN
-RRB-_-RRB-
derived_VBN
from_IN
adherent_JJ
PBMC_NN
cultured_VBN
with_IN
IL-4_NN
and_CC
granulocyte-macrophage_JJ
CSF_NN
._.

We_PRP
first_RB
found_VBD
that_IN
NAC_NN
inhibited_VBD
the_DT
constitutive_JJ
as_RB
well_RB
as_IN
the_DT
LPS-induced_JJ
activity_NN
of_IN
the_DT
transcription_NN
factor_NN
NF-kappaB_NN
._.

In_IN
parallel_NN
,_,
NAC_NN
was_VBD
shown_VBN
to_TO
down-regulate_VB
the_DT
production_NN
of_IN
cytokines_NNS
by_IN
DC_NN
as_RB
well_RB
as_IN
their_PRP$
surface_NN
expression_NN
of_IN
HLA-DR_NN
,_,
CD86_NN
-LRB-_-LRB-
B7-2_NN
-RRB-_-RRB-
,_,
and_CC
CD40_NN
molecules_NNS
both_CC
at_IN
the_DT
basal_JJ
state_NN
and_CC
upon_IN
LPS_NN
activation_NN
._.

NAC_NN
also_RB
inhibited_VBD
DC_NN
responses_NNS
induced_VBN
by_IN
CD40_NN
engagement_NN
._.

The_DT
inhibitory_JJ
effects_NNS
of_IN
NAC_NN
were_VBD
not_RB
due_JJ
to_TO
nonspecific_JJ
toxicity_NN
as_IN
neither_CC
the_DT
viability_NN
of_IN
DC_NN
nor_CC
their_PRP$
mannose_NN
receptor-mediated_JJ
endocytosis_NN
were_VBD
modified_VBN
by_IN
NAC_NN
._.

Finally_RB
,_,
we_PRP
found_VBD
that_IN
the_DT
addition_NN
of_IN
NAC_NN
to_TO
MLR_NN
between_IN
naive_JJ
T_NN
cells_NNS
and_CC
allogeneic_JJ
DC_NNS
resulted_VBD
in_IN
a_DT
profound_JJ
inhibition_NN
of_IN
alloreactive_JJ
responses_NNS
,_,
which_WDT
could_MD
be_VB
attributed_VBN
to_TO
a_DT
defect_NN
of_IN
DC_NN
as_IN
APC-independent_JJ
T_NN
cell_NN
responses_NNS
were_VBD
not_RB
inhibited_VBN
by_IN
NAC_NN
._.

Altogether_RB
,_,
our_PRP$
results_NNS
suggest_VBP
that_IN
NAC_NN
might_MD
impair_VB
the_DT
generation_NN
of_IN
primary_JJ
immune_JJ
responses_NNS
in_IN
humans_NNS
through_IN
its_PRP$
inhibitory_JJ
action_NN
on_IN
DC_NN
._.

